Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
1,099
Views
45
CrossRef citations to date
0
Altmetric
Original Articles

The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts

Felix KreherMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France;Structural Virology, Institut Pasteur, F-75015 Paris, France;Univ Paris Diderot, Sorbonne Paris Cité, F-75205 Paris, France
,
Carole TamiettiMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France;Structural Virology, Institut Pasteur, F-75015 Paris, France
,
Céline GommetMouse Functional Genetics, Institut Pasteur, F-75015 Paris, France;CNRS URA 2578, Institut Pasteur, F-75015 Paris, France;Central Animal Facilities, Institut Pasteur, F-75015 Paris, France
,
Laurent GuillemotMouse Functional Genetics, Institut Pasteur, F-75015 Paris, France;CNRS URA 2578, Institut Pasteur, F-75015 Paris, France
,
Myriam ErmonvalMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France
,
Anna-Bella FaillouxArboviruses and Insect Vectors, Institut Pasteur, F-75015 Paris, France
,
Jean-Jacques PanthierMouse Functional Genetics, Institut Pasteur, F-75015 Paris, France;CNRS URA 2578, Institut Pasteur, F-75015 Paris, France
,
Michèle BouloyMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France
&
Marie FlamandMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France;Structural Virology, Institut Pasteur, F-75015 Paris, FranceCorrespondence[email protected]
 show all
Pages 1-12 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Daubney R, Hudson JR, Garnham PC.Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east africa. J Pathol Bacteriol1931;34: 545–579.
  • Findlay GM.Rift valley fever or enzootic hepatitis. Trans R Soc Trop Med Hyg1932;25: 229–IN211.
  • Bird BH, Ksiazek TG, Nichol ST, Maclachlan NJ.Rift Valley fever virus. J Am Vet Med Assoc2009;234: 883–893.
  • Meegan JM, Hoogstraal H, Moussa MI.An epizootic of Rift Valley fever in Egypt in 1977. Vet Rec1979;105: 124–125.
  • Arthur RR, El-Sharkawy MS, Cope SE et al.Recurrence of Rift Valley fever in Egypt. Lancet1993;342: 1149–1150.
  • Chevalier V, Pepin M, Plee L, Lancelot R.Rift Valley fever—a threat for Europe? Euro Surveill2010;15: 19506.
  • Gale P, Brouwer A, Ramnial V et al.Assessing the impact of climate change on vector-borne viruses in the EU through the elicitation of expert opinion. Epidemiol Infect2009;138: 214–225.
  • Hoogstraal H, Meegan JM, Khalil GM, Adham FK.The Rift Valley fever epizootic in Egypt 1977–78. 2. Ecological and entomological studies. Trans R Soc Trop Med Hyg1979;73: 624–629.
  • Madani TA, Al-Mazrou YY, Al-Jeffri MH et al.Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis2003;37: 1084–1092.
  • Mohamed M, Mosha F, Mghamba J et al.Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg2010;83: 22–27.
  • Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J.Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res2010;41: 61.
  • Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH.Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg1979;73: 630–633.
  • Ikegami T, Makino S.The pathogenesis of Rift Valley fever. Viruses2011;3: 493–519.
  • Plyusnin A, Elliott RM. Bunyaviridae: molecular and cellular biology.Norfolk: Caister Academic Press, 2011.
  • Ikegami T.Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res2012;95: 293–310.
  • Schmaljohn CS, Nichol ST.Bunyaviridae.In: Knipe DM, Howley PM (ed.) Fields virology.5th ed.Philadelphia, PA: Lippincott Williams & Wilkins, 2007: 1741–1789.
  • Kakach LT, Wasmoen TL, Collett MS.Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression. J Virol1988;62: 826–833.
  • Suzich JA, Collett MS.Rift Valley fever virus M segment: cell-free transcription and translation of virus-complementary RNA. Virology1988;164: 478–486.
  • Suzich JA, Kakach LT, Collett MS.Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment. J Virol1990;64: 1549–1555.
  • Wasmoen TL, Kakach LT, Collett MS.Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins. Virology1988;166: 275–280.
  • Gerrard SR, Nichol ST.Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology2007;357: 124–133.
  • Kortekaas J, Oreshkova N, Cobos-Jiménez V et al.Creation of a nonspreading Rift Valley fever virus. J Virol2011;85: 12622–12630.
  • Pichlmair A, Habjan M, Unger H, Weber F.Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus. Vector Borne Zoonotic Dis2010;10: 701–703.
  • Struthers JK, Swanepoel R, Shepherd SP.Protein synthesis in Rift Valley fever virus-infected cells. Virology1984;134: 118–124.
  • Weingartl HM, Zhang SZ, Marszal P, McGreevy A, Burton L, Wilson WC.Rift Valley Fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. PLoS ONE2014;9: e87385.
  • Won S, Ikegami T, Peters CJ, Makino S.NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol2007;81: 13335–13345.
  • Gerrard SR, Bird BH, Albarino CG, Nichol ST.The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology2007;359: 459–465.
  • Won S, Ikegami T, Peters CJ, Makino S.NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol2006;80: 8274–8278.
  • Bird BH, Albarino CG, Nichol ST.Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology2007;362: 10–15.
  • Crabtree MB, Kent Crockett RJ, Bird BH et al.Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Negl Trop Dis2012;6: e1639.
  • Kading RC, Crabtree MB, Bird BH et al.Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes. PLoS Negl Trop Dis2014;8: e2670.
  • Ito N, Takayama-Ito M, Yamada K, Hosokawa J, Sugiyama M, Minamoto N.Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol2003;47: 613–617.
  • Billecocq A, Gauliard N, Le May N, Elliott RM, Flick R, Bouloy M.RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology2008;378: 377–384.
  • do Valle TZ, Billecocq A, Guillemot L et al.A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever. J Immunol2010;185: 6146–6156.
  • Terasaki K, Won S, Makino S.The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts anti-apoptotic function. J Virol2013;87: 676–682.
  • Ross TM, Bhardwaj N, Bissel SJ, Hartman AL, Smith DR.Animal models of Rift Valley fever virus infection. Virus Res2012;163: 417–423.
  • Gommet C, Billecocq A, Jouvion G et al.Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. PLoS Negl Trop Dis2011;5: e1421.
  • Moutailler S, Krida G, Schaffner F, Vazeille M, Failloux AB.Potential vectors of Rift Valley fever virus in the Mediterranean region. Vector Borne Zoonotic Dis2008;8: 749–753.
  • Smith DR. Steele KE, Shamblin J et al.The pathogenesis of Rift Valley fever virus in the mouse model. Virology2010;407: 256–267.
  • Kamal SA.Pathological studies on postvaccinal reactions of Rift Valley fever in goats. Virol J2009;6: 94.
  • McElroy AK, Nichol ST.Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. Virology2011;422: 6–12.
  • Reed C, Steele KE, Honko A, Shamblin J, Hensley LE, Smith DR.Ultrastructural study of Rift Valley fever virus in the mouse model. Virology2012;431: 58–70.
  • Shieh WJ, Paddock CD, Lederman E et al.Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006–2007. Am J Trop Med Hyg2010;83: 38–42.
  • Narayanan A, Popova T, Turell M et al.Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. PLoS ONE2011;6: e20354.
  • Murphy MP.How mitochondria produce reactive oxygen species. Biochem J2009;417: 1.
  • Engdahl C, Naslund J, Lindgren L, Ahlm C, Bucht G.The Rift Valley Fever virus protein NSm and putative cellular protein interactions. Virol J2012;9: 139.
  • Wang T, Campbell RV, Yi MK, Lemon SM, Weinman SA.Role of hepatitis C virus core protein in viral-induced mitochondrial dysfunction. J Viral Hepat2010;17: 784–793.
  • Okuda M, Li K, Beard MR et al.Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology2002;122: 366–375.
  • Waris G, Huh KW, Siddiqui A.Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol2001;21: 7721–7730.
  • Ellis DS, Shirodaria PV, Fleming E, Simpson DI.Morphology and development of Rift Valley fever virus in Vero cell cultures. J Med Virol1988;24: 161–174.
  • Kakach LT, Suzich JA, Collett MS.Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation. Virology1989;170: 505–510.
  • Cavener DR.Comparison of the consensus sequence flanking translational start sites in Drosophila and vertebrates. Nucleic Acids Res1987;15: 1353–1361.
  • Firth AE, Brierley I.Non-canonical translation in RNA viruses. J Gen Virol2012;93: 1385–1409.
  • Greene IP, Wang E, Deardorff ER, Milleron R, Domingo E, Weaver SC.Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells. J Virol2005;79: 14253–14260.
  • Moutailler S, Roche B, Thiberge JM, Caro V, Rougeon F, Failloux AB.Host alternation is necessary to maintain the genome stability of rift valley fever virus. PLoS Negl Trop Dis2011;5: e1156.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.